Table 5.
Medication use at baseline and year one for the ELMI and UC groups expressed as percent values (with absolute numbers).
| Medication | ELMI (n = 151) | UC (n = 151) |
| Lipid lowering | 87% (131) | 80% (121) |
| β-Blocker | 70% (105) | 67% (101) |
| ACE Inhibitor | 43% (65) | 41% (63) |
| Calcium Channel Blocker | 26% (39) | 22% (33) |
| Diuretic | 19% (28) | 15% (23) |
| ASA | 89% (135) | 84% (127) |
| Hypoglycemic Agents | 13% (19) | 17% (25) |
| Angiotensin Receptor Blocker | 5% (7) | 3% (5) |
| Anti-anginal | 19% (29) | 13% (20) |
| Hormone Replacement Therapy (% women) | 19% (5) | 26% (7) |